Is antimicrobial resistance also subject to globalization?
نویسندگان
چکیده
منابع مشابه
Is antimicrobial resistance also subject to globalization?
In recent years one of the more alarming aspects of clinical microbiology has been the dramatic increase in the incidence of resistance to antibacterial agents among pathogens causing nosocomial as well as community-acquired infections. There are profound geographic differences in the incidence of resistance among pathogens of the respiratory tract, only some of which can be explained by the lo...
متن کاملPopulation Mobility, Globalization, and Antimicrobial Drug Resistance
Population mobility is a main factor in globalization of public health threats and risks, specifically distribution of antimicrobial drug-resistant organisms. Drug resistance is a major risk in healthcare settings and is emerging as a problem in community-acquired infections. Traditional health policy approaches have focused on diseases of global public health significance such as tuberculosis,...
متن کامل[International surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use].
With travel and trade within the European Union (EU) increasing over the years, the risk of dissemination of (resistant) pathogens grows. Many studies have shown that there is a growing problem with antimicrobial resistance. For example, methicillin resistant Staphylococcus aureus (MRSA) was initially largely a problem of hospitals, but it is now increasingly reported as a community acquired in...
متن کاملResistance to Antimicrobial Agents
The main reason for the current unsatisfactory situation is that, worldwide, there is no effective regulation of the use of antibiotics. In many nations drugs are freely available "over the counterî and even in countries where most drugs are only available on prescription there may be little control. The practice in some societies of doctors prescribing the most potent drug available just in ca...
متن کاملSepsis kills, antimicrobial resistance is real.
Doshi highlights the danger of speeding new antibiotics to market without adequate testing. However, it is dangerous to question the threat from antimicrobial resistance, and such questions must not detract from the urgent need for new antimicrobial agents. The reduction in mortality from infections worldwide between 1990 and 2013 highlighted by the Global Burden of Disease study coincides with...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Microbiology and Infection
سال: 2002
ISSN: 1198-743X
DOI: 10.1046/j.1469-0691.8.s.3.1.x